US tariffs leave Indian pharma unaffected, industry voices relief
Trump’s new tariffs impose 26% duty on India, while pharma remains exempt. Industry experts weigh in on the impact
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
EY India
Union Budget 2025: Pharma industry applauds key provisions on drug accessibility, R&D boost
Budget provisions focus on customs duty exemptions, R&D funding, and healthcare infrastructure expansion
India’s life sciences sector: A vision for budget FY2025
Focus on enabling MSME business, expanding PLI scheme and research-linked incentives to foster API innovation and tax incentives…
Making sustainability sustainable
Driven by stringent regulations, rising investor expectations, consumer demand, and operational considerations, Viveka…